{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:02:21Z","timestamp":1760266941434},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.leukres.2009.04.028","type":"journal-article","created":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T04:16:47Z","timestamp":1242447407000},"page":"e1-e4","source":"Crossref","is-referenced-by-count":2,"title":["Radioimmunotherapy and secondary leukemia: A case report"],"prefix":"10.1016","volume":"34","author":[{"given":"Michele","family":"Magni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Di Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Testi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonello","family":"Cabras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Devizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Guidetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Matteucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Bonfante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Carniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Carlo-Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro M.","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.04.028_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2141.2001.02955.x","article-title":"Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non Hodgkin's lymphoma","volume":"114","author":"Cortelazzo","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.leukres.2009.04.028_bib2","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.16.8294","article-title":"High-dose 90Y ibritumomab tiuxetan with tandem stem-cell reinfusion: an innovative outpatient preparative regimen for autologous hematopoietic cell transplantation","volume":"26","author":"Devizzi","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2007.11.9248","article-title":"Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non Hodgkin's lymphoma","volume":"26","author":"Krishnan","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.2003.08.043","article-title":"Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non Hodgkin's lymphoma","volume":"21","author":"Witzig","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib5","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2004-12-4690","article-title":"Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non Hodgkin lymphoma treated with tositumomab and I131 tositumomab","volume":"105","author":"Bennet","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.04.028_bib6","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2006.09.2882","article-title":"Treatment-related myelodysplastic sindrome and acute myelogenous leukemia in patients treated with ibritumomab tiuxetan radioimmunotherapy","volume":"25","author":"Czuczman","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/hon.849","article-title":"Acute myeloid leukemia after treatment with 90Y-ibritumomab tiuxetan for follicular lymphoma","author":"Focosi","year":"2008","journal-title":"Hematological Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.leukres.2006.11.011","article-title":"Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non Hodgkin lymphoma","volume":"31","author":"Roboz","year":"2007","journal-title":"Leukemia Research"},{"key":"10.1016\/j.leukres.2009.04.028_bib9","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1080\/1042819021000032971","article-title":"Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non Hodgkin's lymphoma","volume":"43","author":"Nabhan","year":"2002","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.leukres.2009.04.028_bib10","series-title":"An international system for human cytogenetic nomenclature","year":"1995"},{"key":"10.1016\/j.leukres.2009.04.028_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cancergencyto.2004.01.022","article-title":"Deletion of CBFB in a patient with acute myelomocytic leukemia (AML M4Eo) and inversion 16","volume":"154","author":"Egan","year":"2004","journal-title":"Cancer Genetics and Cytogenetics"},{"key":"10.1016\/j.leukres.2009.04.028_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00428-005-0070-8","article-title":"Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis","volume":"447","author":"Kremer","year":"2005","journal-title":"Virchows Archives"},{"key":"10.1016\/j.leukres.2009.04.028_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.leukres.2006.08.009","article-title":"Detection of the CBFB\/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single institution study of 224 Japanese AML patients","volume":"31","author":"Monma","year":"2007","journal-title":"Leukemia Research"},{"key":"10.1016\/j.leukres.2009.04.028_bib14","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2002-02-0420","article-title":"Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors","volume":"100","author":"Kottaridis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.04.028_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukemias","volume":"121","author":"Care","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.leukres.2009.04.028_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1999.01449.x","article-title":"c-KIT proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukemia","volume":"105","author":"Gari","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.leukres.2009.04.028_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/sj.leu.2403652","article-title":"Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF","volume":"19","author":"Ricca","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.04.028_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2141.1997.2933107.x","article-title":"Underestimation of inversion (16) in acute myeloid leukemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation","volume":"98","author":"Ritter","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.leukres.2009.04.028_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1182\/blood-2006-06-030312","article-title":"FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.04.028_bib20","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.04.028_bib21","first-page":"106","article-title":"Second hit mutations in the RTK\/RAS signalling pathway in acute myeloid leukemia with inv(16)","volume":"89","author":"Valk","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.04.028_bib22","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1200\/JCO.2005.10.330","article-title":"Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphoma","volume":"23","author":"Bhatia","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.leukres.2009.04.028_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bcmd.1996.0110","article-title":"N-RAS mutations in radiation-induced murine leukemic cells","volume":"22","author":"Rithidech","year":"1996","journal-title":"Blood Cells Molecular Disease"},{"key":"10.1016\/j.leukres.2009.04.028_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ijc.2910460511","article-title":"Chromosome aberrations induced by etoposide (VP-16) are not random","volume":"15","author":"Maraschin","year":"1990","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.leukres.2009.04.028_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1383-5718(98)00169-7","article-title":"Analysis of bleomycin- and cytosine arabinoside-induced chromosome aberrations involving chromosomes 1 and 4 by painting FISH","volume":"439","author":"Puerto","year":"1999","journal-title":"Mutation Research"},{"key":"10.1016\/j.leukres.2009.04.028_bib26","first-page":"3557","article-title":"Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes","volume":"54","author":"Ohyashiki","year":"1994","journal-title":"Cancer Research"},{"key":"10.1016\/j.leukres.2009.04.028_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bmt.1702144","article-title":"Shortening of telomeres in recipient of both autologous and allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Akiyama","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.leukres.2009.04.028_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.leu.2401618","article-title":"A hypotesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies","volume":"14","author":"Rosenfeld","year":"2000","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T01:02:37Z","timestamp":1558314157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609002148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0145212609002148"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.04.028","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}